Induction of apoptosis by IFNγ in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit

Cell Death and Differentiation

Volumn 6, Issue 7, 1999, Pages 652-660

  Bernassola, Francesca ^a   Scheuerpflug, Christian ^b   Herr, Ingrid ^b   Krammer, Peter H ^c   Debatin, Klaus Michael ^b   Melino, Gerry ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; CD95 (APO 1, Fas); Cell death; IFN ; Neuroblastoma

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; CYTOKINE; FAS ANTIGEN; FAS LIGAND; GAMMA INTERFERON; FASLG PROTEIN, HUMAN; LIGAND; MEMBRANE PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RECOMBINANT GAMMA INTERFERON;

APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL DEATH; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR CLONING; NEUROBLASTOMA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CELL CULTURE; DRUG EFFECT; ENZYMOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; NEUROBLASTOMA; PATHOLOGY; UPREGULATION;

ANTIGENS, CD95; APOPTOSIS; FAS LIGAND PROTEIN; HUMANS; INTERFERON-GAMMA, RECOMBINANT; LIGANDS; MEMBRANE GLYCOPROTEINS; NEUROBLASTOMA; SIGNAL TRANSDUCTION; TRANSGLUTAMINASES; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0032588320     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400537     Document Type: Article

References (48)

1. Trauth BC, Klas C, Peter AMJ, Matz S, Moller P, Falk W, Debatin KM and Krammer PH (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305
2. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH and Peter ME (1995) Cytoxicity-dependent APO-1 (Fas/CD95)-associated proteins (CAP) form a death-inducing signalling complex (DISC) with the receptor. EMBO J. 14: 5579-5588
3. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signalling complex. Cell 85: 817-827
4. Muzio M, Stickwell BR, Stennicke HR and Salvesen GS (1998) An induced proximity model for caspase-8 activation. J. Biol. Chem. 273: 2926-2930
5. Yang X, Chang HY and Baltimore D (1998) Autoproteolytic activation of procaspases by oligomerization. Mol. Cell 1: 319-325
6. Salvesen GS and Dixit VM (1997) Caspases: intracellular signalling by proteolysis. Cell 91: 443-446
7. Kuwana T, Smith JJ, Muzio M, Dixit V, Newmeyer DD and Kornbluth S (1998) Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochromec. J. Biol. Chem. 273: 16589-16594
8. Zou H, Henzel WJ, Liu X, Lutschg A and Wang X (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405-413
9. Li P, Nijhavan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489
10. Srinivasula SM, Ahmad M, Fernandes-Alnemri T and Alnemri ES (1998) Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell 1: 949-957
11. Liu X, Slaughter C and Wang X (1997) DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89: 175-184
12. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A and Nagata S (1998) A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391: 43-50
13. Sakahira H, Enari M and Nagata S (1998) Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391: 96-99
14. Falk MH, Trauth BC, Debatin KM, Klas C, Gregory CD, Rickinson AB, Calender A, Lenoir GM, Ellwart JW, Krammer PH and Bornkamm GW (1992) Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood 79: 3300-3306
15. Debatin KM, Goldman CK, Waldmann TA and Krammer PH (1993) APO-1-induced apoptosis of leukemia cells from patients with adult T-cell leukemia. Blood 81: 2972-2977
16. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y and Fontana A (1994) Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells: induction and modulation of sensitivity by cytokines. J. Clin. Invest. 94: 954-964
17. Hahne M, Rimoldi D, Schroter M, Romero P, Schreier M, French LE., Schneider P, Bornand T, Fontana A, Lienard D, Cerottini JC and Tschopp J (1996) Melanoma cell expression of Fas(APO-1/CD95) ligand: implications for tumor immune escape. Science 274: 1363-1366
18. Strand S, Hofmann WJ, Hug H, Muller M, Otto G, Strand D, Mariani S, Stremmel W, Krammer PH and Galle PR (1996) Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells. A mechanism of immune evasion? Nature Med. 2: 1361-1366
19. Herr I, Wilhelm D, Bohler T, Angel P and Debatin KM (1997) Activation of CD95 (APO-1/Fas) signalling by ceramide mediates cancer therapy-induced apoptosis. EMBO J. 16: 6200-6208
20. Friesen C, Herr I, Krammer PH and Debatin KM (1996) Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nature Med. 2: 574-577
21. Fulda S, Sieverts H, Friesen C, Herr I and Debatin KM (1997) The CD95 (APO-1/ Fas) system mediates drug induced apoptosis in neuroblastoma cells. Cancer Res. 57: 3823-3829
22. Muller M, Strand S, Hug H, Heinemann EM, Walczac H, Hofmann WJ, Stremmel W, Krammer PH and Galle PR (1997) Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J. Clin. Invest. 99: 403-413
23. Kasibhatla S, Brunner T, Genestier L, Echeverri F, Mahboubi A and Green DR (1998) DNA damaging agents induce expression of Fas-Ligand and subsequent apoptosis in T lymphocytes via the activation of NF-KB and AP-1. Mol. Cell 1: 543-551
24. Ponzoni M, Casalaro A, Lanciotti M, Montaldo PG and Cornaglia-Ferraris P (1992) The combination of γ-interferon and tumor necrosis factor causes a rapid and extensive differentiation of human neuroblastoma cells. Cancer Res. 52: 931-939
25. Fellenberg J, Mau H, Scheuerpflug C, Ewerbeck V and Debatin KM (1997) Modulation of resistence to anti-APO-1-induced apoptosis in osteosarcoma cells by cytokines. Int. J. Cancer 72: 536-542
26. Montaldo PG, Chiesa V, Bado M, Raffaghello L, Rozzo C and Ponzoni M (1997) Induction of differentiation and apoptosis by interferon-γ in human neuroblastoma cells in vitro as a dual and alternative early biological response. Cell Death Differ. 4: 150-158
27. Ossina NK, Cannas A, Powers VC, Fitzpatrick PA, Knight JD, Gilbert JR, Shekhtman EM, Tomei LD, Umansky SR and Kiefer MC (1997) Interferon-γ modulates a p53-independent apoptotic pathway and apoptosis-related gene expression. J. Biol. Chem. 272: 16351-16357
28. Muschen M, Warskulat U, Schmidt B, Schulz WA, Haussinger D (1998) Regulation of CD95 (Apo-1/Fas) ligand and receptor expression in human embryonal carcinoma cells by Interferon gamma and all-trans retinoic acid. Biol. Chem. 379: 1083-1091
29. Dhein J, Daniel PT, Trauth BC, Oehm A, Moller P and Krarnmer PH (1992) Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol. 149: 3166-3173
30. Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA and Henson PM (1992) Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J. Immunol. 149: 4029-4035
31. Dhein J, Walczak H, Baumler C, Debatin KM and Krammer PH (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373: 438-441
32. Ju S-T, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ and Marshak-Rothstein A (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373: 444-448
33. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR (1995) Cell-autonomous Fas (CD95)/ Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373: 441-444
34. Melino G, Annicchiarico-Petruzzelli M, Piredda L, Candi E, Gentile V, Davies PJA and Piacentini M (1994) Tissue transglutaminase and apoplosis: sense and antisense transfection studies with human neuroblastoma cells. Mol. Cel. Biol. 14: 6584-6596
35. Melino G, Draoui M, Bellincampi L, Bernassola F, Bernardini S, Piacentini M, Reichert U and Cohen P (1997) Retinoic acid receptors α and γ mediate the induction of "tissue" transglutaminase activity and apoptosis in human neuroblastoma cells. Exp. Cell. Res. 235: 55-61
36. Piacentini M, Annicchiarico-Petruzzelli M, Oliverio S, Piredda L, Biedler JL and Melino G (1992) Phenotype-specific "tissue" transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: correlation with cell death by apoptosis. Int. J. Cancer 52: 271-278
37. Piacentini M, Piredda L, Starace D, Annicchiarico-Petruzzelli M, Mattei M, Oliverio S, Farrace MG and Melino G (1996) Differential growth properties of S- and N-type human neuroblastoma cell variants transplanted into SCID mice: correlation with apoptosis and effect of ethanol. J. Path. 180: 415-422
38. Krammer PH (1997) The tumor strikes back: new data on expression of the CD95 (APO-1/Fas) receptor/ligand system may cause paradigm changes in our view on drug treatment and tumor immunology. Cell Death Differ. 4 362-364
39. Melino G, Bernassola F, Knight RA, Corasaniti MT, Nistico' G and Finazzi-Agro' A (1997) S-nitrosylation regulates apoptosis. Nature 388: 432-433
40. Wallach D (1997) Placing death under control. Nature 388: 123-126
41. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer J-L, Schroter M, Scaffidi C, Krammer PH Peter ME and Tschopp J (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent apoplosis induced by death receptors. Nature 386: 517-521
42. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE and Tschopp J (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388: 190-195
43. Rasper DM, Vaillancourt JP, Hadano S, Houtzager VM, Seiden I, Keen SLC, Tawa P, Xanthoudakis S, Nasir J, Martindale D, Koop BF, Peterson EP, Thornberry AA, Huang J-Q, MacPherson DP, Black SC, Hornung F, Lenardo MJ, Hayden MR, Roy S and Nicholson DW (1998) Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1-receptor complex. Cell. Death Differ. 5: 271-288
44. Griffith T, Brunner T, Fletcher S, Green D and Ferguson T (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege Science 270: 1189-1192
45. Debatin KM (1997) Cytotoxic drugs, programmed cell death, and the immune system: defining new roles in an old play. J. Natl. Cancer Inst. 89: 750-751
46. Hueber AO, Zornig M, Lyon D, Suda T, Nagata S and Evan GI (1997) Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science 278: 1305-1309
47. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth B, Ponstingl H and Krammer PH (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J. Biol. Chem. 267: 10709-10715
48. Herr I, Balemans L, Bohler T, Walczak H and Debatin KM (1996) Monitoring of CD95 (APO-1/Fas) ligand expression in human T cells by quantitative RT-PCR. Cell Death Differ. 3: 299-305